SCHEMBL29375982

SCHEMBL29375982

CC(C)CCCCCCCCCCCCCCC(=O)OCC(O)CO.CC(C)CCCCCCCCCCCCCCC(=O)OCC(O)CO

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.71
DUSP3 P51452 1/20 0.71
MEN1 O00255 1/20 0.71
KMT2A Q03164 1/20 0.71
LMNA P02545 1/20 0.71
DGKA P23743 1/20 0.60
MAPT P10636 1/20 0.51
FAAH O00519 4/20 0.50
ENPP2 Q13822 2/20 0.47
LPAR6 P43657 1/20 0.47
LPAR1 Q92633 1/20 0.47
LPAR4 Q99677 1/20 0.47
LPAR5 Q9H1C0 1/20 0.47
LPAR2 Q9HBW0 1/20 0.47
LPAR3 Q9UBY5 1/20 0.47
PRKCA P17252 3/20 0.46
PRKCE Q02156 1/20 0.46
PRKCQ Q04759 1/20 0.46
PRKCD Q05655 1/20 0.46
CNR2 P34972 3/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17867362 1.00 KDM4E (0.71) KDM4EDUSP3MEN1KMT2ALMNA
SCHEMBL17867087 1.00 KDM4E (0.71) KDM4EDUSP3MEN1KMT2ALMNA
SCHEMBL17866968 1.00 KDM4E (0.71) KDM4EDUSP3MEN1KMT2ALMNA
SCHEMBL29402308 1.00 KDM4E (0.71) KDM4EDUSP3MEN1KMT2ALMNA
SCHEMBL27084610 1.00 KDM4E (0.71) KDM4EDUSP3MEN1KMT2ALMNA
SCHEMBL17866841 1.00 KDM4E (0.71) KDM4EDUSP3MEN1KMT2ALMNA
SCHEMBL29362820 1.00 KDM4E (0.71) KDM4EDUSP3MEN1KMT2ALMNA
SCHEMBL2516961 1.00 KDM4E (0.71) KDM4EDUSP3MEN1KMT2ALMNA
SCHEMBL30023815 1.00 KDM4E (0.71) KDM4EDUSP3MEN1KMT2ALMNA
SCHEMBL609590 0.98 KDM4E (0.68) KDM4EDUSP3MEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 185 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12296110-B2 Hydrophilic medical products and hydration mediums for hydrating the same HOLLISTER INCORPORATED (US) 2025-05-13 US claimed
US-12246270-B2 Biobased defoamer compositions and methods of preparation thereof KRATON CHEMICAL, LLC (US) 2025-03-11 US claimed
EP-4015008-B1 PACKAGE CONTAINING HYDROPHILIC URINARY CATHETER AND FOAMED HYDRATION MEDIUM FOR ITS HYDRATION HOLLISTER INC (US) 2024-11-13 EP claimed
WO-2024142983-A1 SOLID COSMETIC FOR LIPS 株式会社 資生堂 2024-07-04 WO claimed
US-20240066436-A1 BIOBASED DEFOAMER COMPOSITIONS AND METHODS OF PREPARATION THEREOF KRATON CHEMICAL, LLC (US) 2024-02-29 US claimed
WO-2023058469-A1 COSMETIC COMPOSITION 株式会社 資生堂 2023-04-13 WO claimed
EP-4147762-A1 BIOBASED DEFOAMER COMPOSITIONS AND METHODS OF PREPARATION THEREOF Kraton Chemical, LLC (US) 2023-03-15 EP claimed
US-11554086-B2 Cosmetic composition comprising glycolic acid and methods of use L'OREAL (FR) 2023-01-17 US claimed
US-20220241553-A1 HYDROPHILIC MEDICAL PRODUCTS AND HYDRATION MEDIUMS FOR HYDRATING THE SAME HOLLISTER INCORPORATED 2022-08-04 US claimed
EP-4015008-A1 PACKAGE CONTAINING HYDROPHILIC URINARY CATHETER AND FOAMED HYDRATION MEDIUM FOR ITS HYDRATION Hollister Incorporated (US) 2022-06-22 EP claimed
CN-114632030-A Water-in-oil type emulsified solid cosmetic 株式会社资生堂 2022-06-17 CN claimed
EP-4008305-A1 OIL-IN-WATER COMPOSITION COMPRISING OIL DROPLETS WITH DIAMETER OF 0,1MM OR MORE Clariant International Ltd (CH) 2022-06-08 EP claimed
US-11338109-B2 Hydrophilic medical products and hydration mediums for hydrating the same HOLLISTER INCORPORATED (US) 2022-05-24 US claimed
US-20260144718-A1 SOLID POWDER COSMETIC KOSE CORPORATION (JP) 2026-05-28 US disclosed
US-20260137841-A1 HYDROPHILIC MEDICAL PRODUCTS AND HYDRATION MEDIUMS FOR HYDRATING THE SAME HOLLISTER INCORPORATED (US) 2026-05-21 US disclosed
US-12582590-B2 Transparent liquid composition and cosmetic containing said composition SEIWA KASEI COMPANY, LIMITED (JP) 2026-03-24 US disclosed
CN-114173752-A Cellulose-containing pigments 日产化学株式会社 2022-03-11 CN disclosed
US-20220040059-A1 OIL-IN-WATER COSMETIC AND METHOD FOR PRODUCING THE SAME L V M H RECHERCHE (FR) 2022-02-10 US disclosed
EP-3950071-A1 CORE-SHELL STRUCTURE, PREPARATION, MEDICINE FOR EXTERNAL APPLICATION, TAPE AGENT AND COSMETIC PRODUCT SEKISUI CHEMICAL CO., LTD. (JP) 2022-02-09 EP disclosed
US-20220031578-A1 COATING FILM FOR SKIN KAO CORPORATION (JP) 2022-02-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260137841-A1 HYDROPHILIC MEDICAL PRODUCTS AND HYDRATION MEDIUMS FOR HYDRATING THE SAME AQP1, AQP3, AQP4 KDM4E 4382/4885DUSP3 3884/4885MEN1 1910/4885
US-11554086-B2 Cosmetic composition comprising glycolic acid and methods of use CUTA, UGCG, DGKI KDM4E 3235/4885DUSP3 1732/4885MEN1 2380/4885
US-20260144718-A1 SOLID POWDER COSMETIC CUTA, CFB, FLNB KDM4E 3490/4885DUSP3 4689/4885MEN1 277/4885
US-12582590-B2 Transparent liquid composition and cosmetic containing said composition GK, CUTA, GHDC KDM4E 4154/4885DUSP3 3892/4885MEN1 1200/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.